Evidence map›Paper›PMID 34539059›Full record

ReviewMRS bulletin2021

Recent developments in filtration media and respirator technology in response to COVID-19.

Peter L Wang, Alex Roschli, M Parans Paranthaman, Merlin Theodore, Corson L Cramer, Chris Zangmeister, Yuepeng Zhang, Jeffrey J Urban, Lonnie Love

Open access · hybridAbstract readReview
In one paragraph

Review in MRS bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Poly(3-hydroxybutyrate-ACS omega · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Peter L WangOak Ridge National Laboratory, Oak Ridge, TN USA.ORCID 0000-0002-9187-4656
Alex RoschliOak Ridge National Laboratory, Oak Ridge, TN USA.
M Parans ParanthamanOak Ridge National Laboratory, Oak Ridge, TN USA.ORCID 0000-0003-3009-8531
Merlin TheodoreOak Ridge National Laboratory, Oak Ridge, TN USA.
Corson L CramerOak Ridge National Laboratory, Oak Ridge, TN USA.
Chris ZangmeisterNational Institute of Standards and Technology, Gaithersburg, USA.
Yuepeng ZhangArgonne National Laboratory, Lemont, USA.
Jeffrey J UrbanLawrence Berkeley National Laboratory, Berkeley, USA.
Lonnie LoveOak Ridge National Laboratory, Oak Ridge, TN USA.
Oak Ridge National Laboratory · USArgonne National Laboratory · USLawrence Berkeley National Laboratory · USNational Institute of Standards and Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract: The COVID-19 pandemic triggered a surge in demand for N95 or equivalent respirators that the global supply chain was unable to satisfy. This shortage in critical equipment has inspired research that addresses the immediate problems and has accelerated the development of the next-generation filtration media and respirators. This article provides a brief review of the most recent work with regard to face respirators and filtration media. We discuss filtration efficiency of the widely utilized cloth masks. Next, the sterilization of and reuse of existing N95 respirators to extend the existing stockpile is discussed. To expand near-term supplies, optimization of current manufacturing methods, such as melt-blown processes and electrospinning, has been explored. Future manufacturing methods have been investigated to address long-term supply shortages. Novel materials with antiviral and sterilizable properties with the ability for multiple reuses have been developed and will contribute to the development of the next generation of longer lasting multi-use N95 respirators. Finally, additively manufactured respirators are reviewed, which enable a rapidly deployable source of reusable respirators that can use any filtration fabric. Graphic abstract:

Indexed as

Antiviral propertiesFiltration efficiencyManufacturing methodsN95 respirators and filter

Identifiers

PMID34539059
PMCPMC8442655
OpenAlexW3201081998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.